• About
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Strategic Investors
    • Careers
      • Open Positions
  • Science
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
      • Expanded Access
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
  • Investors & Media
    • News
    • Events & Presentations
    • Stock Information
    • Financials
    • Governance
    • Resources
  • Contact
Gemini Therapeutics Logo
  • About
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Strategic Investors
    • Careers
      • Open Positions
  • Science
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
      • Expanded Access
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
  • Investors & Media
    • News
    • Events & Presentations
    • Stock Information
    • Financials
    • Governance
    • Resources
  • Contact
Home About Scientific Advisory Board Napoleone Ferrara, M.D.

Napoleone Ferrara, M.D.

University of California San Diego
Michael Ehrmann, Ph.D.
Bruce Jaffee, Ph.D.
Gemini Therapeutics Logo
  • Contact
  • Privacy Policy
  • Follow:
© 2021 Gemini Therapeutics